Evidence map›Paper›PMID 30042203›Full record

ArticlemBio2018

Vibrio parahaemolyticus Senses Intracellular K

Sarunporn Tandhavanant, Shigeaki Matsuda, Hirotaka Hiyoshi, Tetsuya Iida, Toshio Kodama

Open access · goldAbstract read
In one paragraph

Article in mBio, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed
1.7field-weighted citation impact, top 18% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed, 18 citations in OpenAlex.

  1. Article
  2. BopN is a Gatekeeper of theMicrobiology spectrum · 2023
    Article
  3. Microbial genomics · 2023
    Article
  4. Article
  5. Article
  6. TrkA serves as a virulence modulator inFrontiers in cellular and infection microbiology · 2022
    Article
  7. Article
  8. Article
  9. Review
  10. Article
  11. Adaptations ofFrontiers in microbiology · 2021
    Review
  12. Frontiers in cellular and infection microbiology · 2020
    Review
  13. Vibrio variations on a type three theme.Current opinion in microbiology · 2019
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 2 institutions in 2 countries.

Sarunporn TandhavanantDepartment of Bacterial Infections, Research Institute for Microbial Diseases, Osaka University, Osaka, Japan.
Shigeaki MatsudaDepartment of Bacterial Infections, Research Institute for Microbial Diseases, Osaka University, Osaka, Japan.
Hirotaka HiyoshiDepartment of Bacterial Infections, Research Institute for Microbial Diseases, Osaka University, Osaka, Japan.
Tetsuya IidaDepartment of Bacterial Infections, Research Institute for Microbial Diseases, Osaka University, Osaka, Japan.
Toshio KodamaDepartment of Bacterial Infections, Research Institute for Microbial Diseases, Osaka University, Osaka, Japan kodama@biken.osaka-u.ac.jp.
Osaka University · JPUniversity of California, Davis · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Many Gram-negative bacterial symbionts and pathogens employ a type III secretion system (T3SS) to live in contact with eukaryotic cells. Because T3SSs inject bacterial proteins (effectors) directly into host cells, the switching of secretory substrates between translocators and effectors in response to host cell attachment is a crucial step for the effective delivery of effectors. Here, we show that the protein secretion switch of

Indexed as

Bacterial ProteinsCytoplasmGene Expression Regulation, BacterialPotassiumPotassium ChlorideProtein TransportType III Secretion SystemsVibrio parahaemolyticusBacterial ProteinsPotassiumPotassium ChlorideType III Secretion SystemseffectorgatekeeperT3SStranslocatorVibrio parahaemolyticus

Identifiers

PMID30042203
PMCPMC6058294
OpenAlexW2883592408

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.